Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor Paul Tapang, Terrance J. Magoc, et al. Mol Cancer Ther 2006;5:995-1006
Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors Patrick A. Marcotte, J. Owen McCall, et al. Mol Cancer Ther 2006;5:1007-1013
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.